Related Experiment Videos
Quantitative angiographic analysis of PTCA-induced coronary vasoconstriction in single-vessel coronary artery disease
R Altstidl1, C Goth, H Lehmkuhl
1Medizinische Klinik II mit Poliklinik, University of Erlangen-Nuremberg, Germany.
Insights
Percutaneous transluminal coronary angioplasty (PTCA) causes moderate coronary vasoconstriction, which is diffuse and not linked to stenosis severity. This vasoconstriction is reversible with isosonbide dinitrate (ISDN) and does not predict restenosis.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Biology
Background:
- Percutaneous transluminal coronary angioplasty (PTCA) is a common procedure for treating coronary artery disease.
- Understanding the vascular response post-PTCA is crucial for optimizing patient outcomes.
- Coronary vasoconstriction following PTCA has been observed but its characteristics and implications require further elucidation.
Purpose of the Study:
- To investigate the degree and extent of coronary vasoconstriction after PTCA.
- To determine if PTCA-induced vasoconstriction correlates with lesion severity or mechanical factors.
- To assess the reversibility of vasoconstriction with isosonbide dinitrate (ISDN) and its relation to restenosis.
Main Methods:
- Quantitative coronary angiography was used to measure coronary diameter changes.
- Measurements were taken before PTCA, after PTCA, and after ISDN administration.
- Comparisons were made with ergonovine-induced vasoconstriction and restenosis rates at 4-month follow-up.
Main Results:
- PTCA induced moderate, significant vasoconstriction in segments both distal and proximal to the intervention site.
- No correlation was found between vasoconstriction and lesion severity or PTCA-induced mechanical stretch.
- Isosonbide dinitrate (ISDN) caused significant vasodilatation, indicating ISDN-reversible vasoconstriction.
- Vasoconstriction levels were comparable to ergonovine-induced constriction and did not differ between patients with or without restenosis.
Conclusions:
- Coronary vasoconstriction following PTCA is a diffuse phenomenon.
- The underlying mechanism of PTCA-induced vasoconstriction appears complex and not directly related to mechanical factors or stenosis severity.
- ISDN-reversible vasoconstriction post-PTCA is within physiological limits and does not predict restenosis.
Abstract:
Quantitative coronary angiography was applied to investigate the degree and extent of coronary vasoconstriction following percutaneous transluminal coronary angioplasty (PTCA) in single-vessel disease of segments distal to the PTCA site (n = 46) and of control segments in nonmanipulated vessels (n = 33) before PTCA, 15 minutes after PTCA, and again 10 minutes after 10 mg sublingual isosonbide dinitrate (ISDN) in 46 patients receiving neither nitrates nor calcium channel blockers prior to PTCA. Furthermore, the degree of coronary vasoconstriction was compared with ergonovine-induced vasoconstriction (n = 8) as well as in patients with and without restenosis during follow-up angiography 4 months later. PTCA induced a moderate, but significant, vasoconstriction in both distal and control segments, with a reduction in coronary diameter from 2.34 +/- 0.58 to 2.26 +/- 0.55 mm (P = 0.011) and from 2.70 +/- 0.62 to 2.60 +/- 0.65 mm (P = 0.004), respectively. No correlation between the degree of vasoconstriction on the one side and lesion severity and PTCA-induced mechanical stretch, judged by the sum of the products of inflation pressure and time, on the other side was found. Vasoconstriction was within the limits achievable with the potent vasoconstrictor ergonovine and did not differ in patients with or without restenosis. ISDN led to a significant vasodilatation in all segments. In conclusion, coronary vasoconstriction following PTCA is present in the coronary tree in a rather diffuse way. It is not associated with stenosis severity or PTCA-induced mechanical stretch, suggesting a complex underlying mechanism. ISDN-reversible vasoconstriction was within the limits achievable with ergonovine and did not differ with regard to restenosis.